09/03/2026
Moleculin Biotech, Inc. (MBRX) meets investors at the 5th Annual ROTH Healthcare Opportunities Conference, hosted by ROTH Capital Partners at The Metropolitan Club in New York City on Tuesday, September 29, 2026, where B2i Digital is the Marketing Partner.
The 5th Annual ROTH Healthcare Opportunities Conference is a B2i Digital Featured Conference. See event details and profiles of participating companies at: https://b2idigital.com/5th-annual-roth-healthcare-opportunities-conference
Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company’s lead program, Annamycin (also known as naxtarubicin), is a highly efficacious and well tolerated anthracycline designed to avoid multidrug resistance mechanisms and to lack the cardiotoxicity common with currently prescribed anthracyclines. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.
Credit to the team at ROTH: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia "Charo" Montano, Amanda McAdams, Russ Nudelman, Andrew Kellogg, Matt Robinson, CPA, David Farina, Jonathan Aschoff, Ph.D. and Harry Fong.
ROTH built the day around time with management, in a 25-minute 1-on-1 and small group format running from 8:00 AM to 4:30 PM that gives institutional investors extended interaction with the executives running these companies, alongside themed panel discussions and a keynote. This is an invitation-only event and registration is subject to approval by ROTH.
To request registration: https://www.meetmax.com/sched/event_139361/conference_home.html
B2i Digital, The Capital Markets Matchmaker℠, carries each participating company's story From Marketing to Meetings℠, across its media network with a combined monthly audience of more than 330 million and its own community of 1.7 million+ investors and market participants.
ROTH is a relationship-driven investment bank focused on serving growth companies and their investors across capital raising, equity research, sales and trading, mergers and acquisitions (M&A) advisory, and corporate access. For more information, visit www.roth.com.
Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com.
B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer.